Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

Google has revealed its Gemini 2.5, which allows it to take a significant leap forward in the AI capabilities. Gemini 2.5 Pro ...

Gemini 2.5 Pro has been released by Google as the company’s most intelligent AI model yet and here’s what it has to offer.

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

Explore Google's new Gemini 2.5 Pro's advanced AI features, from coding to ethical reasoning, and its transformative impact across industries ...

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), NVIDIA Corp. (NVDA ...

Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...

Alphabet Inc's Google (NASDAQ:GOOGL) has revealed Gemini 2.5, representing a significant leap forward in its artificial intelligence capabilities. The initial release, Gemini 2.5 Pro Experimental, ...

By investing in adaptable e-invoicing solutions, companies can position themselves for success in an evolving regulatory ...

Catcha Digital is making a move into banking software by acquiring a controlling stake in Theta Service Partner, a company ...

Gemini 2.5 Pro ships with a 1 million token context window, soon expanding to 2 million tokens. This enables it to process ...